-
-
-
-
-
-
-
4 themes and 4 key biotech stocks for 2025: Jefferies
-
-
-
-
-
-
-
Gilead drops 11% after lung cancer drug trial fails, analyst says stock is 'overreacting'
-
-
-
-
-
-
-
Jefferies Positive on Gilead (GILD) Into ESMO, Says Stock Cheap with ~5% Dividend Yield
-
-
-
-
-
-
-
Gilead earnings hurt by legal settlement, other charges
-
-
-
-
-
-
-
Gilead Sciences (GILD) Management Meeting Reveals 5 Takeaways and a Path to $75 - Jefferies
-
-
-
-
-
-
-
U.S. drugmaker earnings heat up this week with spotlight on vaccine news
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/21: (ACB) (KDMN) (TJX) Higher; (SCPH) (RUTH) (FLXN) Lower (more...)
-
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

